Reduction of inflammatory reaction of poly(D,L-lactic-co-glycolic acid) using demineralized bone particles

Tissue Engineering - Part A.

Volumn 14, Issue 4, 2008, Pages 539-547

  Yoon, Sun Jung ^a   Kim, Soon Hee ^a   Ha, Hyun Jung ^a   Ko, Youn Kyung ^a   So, Jung Won ^a   Kim, Moon Suk ^b   Yang, Young Il ^c   Khang, Gilson ^a   Rhee, John M ^a   Lee, Hai Bang ^b  

^a Chonbuk National University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

^c Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; METABOLITES; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; DEMINERALIZED BONE PARTICLES (DBPS);

BONE;

INTERLEUKIN 1BETA; MESSENGER RNA; POLYGLACTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BONE MATRIX; CELL ADHESION; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; ENCAPSULATION; FIBROBLAST CULTURE; FILM; GENE EXPRESSION; GIANT CELL; HISTOPATHOLOGY; IMPLANT; IN VIVO STUDY; INFLAMMATION; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RAT;

EID: 42049122100     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/tea.2007.0129     Document Type: Article

References (25)

1. Patil, S.D., Papadmitrakopoulos, F., and Burgess, D.J. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release 117, 68, 2007.
2. Kose, G.R., Korkusuz, F., Korkusuz, P., and Hasirci, V. In vitro tissue engineering of bone using poly(3-hydroxybutyric acid-co-3-hydroxyvaleic acid) and collagen scaffold. Tissue Eng 10, 1234, 2004.
3. Klueh, U., Dorsky, D.I., Moussy, F., and Kreutzer, D.L. Ex ova chick chorioallantoic membrane as a novel model for evaluation of tissue responses to biomaterials and implants. J Biomed Mater Res A 67, 838, 2003.
4. Khang, G., Lee, S.G., Kim, M.S., and Lee, H.B. Biomaterials: tissue-engineering and scaffolds. In: Webster, S., ed. Encyclopedia of Medical Devices and Instrumentation, 2nd ed. New York: John & Wiley Press, 2006, pp. 366-383.
5. Bostman, O. Absorbable implants for the fixation of fractures. J Bone Joint Surg Am 73, 148, 1991.
6. Taylor, M.S., Daniels, A.U., Andriano, K.P., and Heller, J. Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. J Appl Biomater 5, 151, 1994.
7. Klompmaker, J., Jansen, H.W., Veth, R.P., de Groot, J.H., Nijenhuis, A.J., and Pennings, A.J. Porous polymer implant for repair of meniscal lesions: a preliminary study in dogs. Biomaterials 12, 810, 1991.
8. Lickorish, D., Guan, L., and Davies, J.E. A three-phase, fully resorbable, polyester/calcium phosphate scaffold for bone tissue engineering: Evolution of scaffold design. Biomaterials 28, 1495, 2007.
9. Iwasaki, Y., Sawada, S., Ishihara, K., Khang, G., and Lee, H.B. Reduction of surface-induced inflammatory reaction on PLGA/MPC polymer blend. Biomaterials 23, 3897, 2002.
10. Ko, Y.K., Kim, S.H., Jeong, J.S., Ha, H.J., Yoon, S.J., Rhee, J.M., Kim, M.S., Lee, H.B., and Khang, G. Biodisc Tissue-engineered using PLGA/DBP hybrid scaffold. Polymer (Korea) 31, 14, 2007.
11. Jang, J.W., Park, K.S., Kim, S.H., Park, J.S., Kim, M.S., Han, C.W., Rhee, J.M., Khang, G., and Lee, H.B. Tissue engineered bone regeneration using DBP-loaded PLGA scaffold in rabbit model. Tissue Eng Reg Med 2, 34, 2005.
12. Thomas, C.B., Jenkins, L., Kellam, J.F., and Burg, K.J.L. Endpoint verification of bone demineralization for tissue engineering applications. In: Schutte, E. and Picciolo, G.L., eds. Tissue Engineered Medical Products: ASTM 1452. West Conshohocken, PA: ASTM International, 2004, pp. 90-99.
13. Eid, K., Zelicof, S., Perona, B.P., Sledge, C.B., and Glowacki, J. Tissue reactions to particles of bone-substitute materials in intraosseous and heterotopic sites in rats: discrimination of osteoinduction, osteocompatibility, and inflammation. J Orthop Res 19, 962, 2001.
14. Choi, B.S., Kim, S.H., Yoon, S.J., Ha, H.J., Kim, M.S., Yang, Y.I., Son, Y., Khang, G., Rhee, J.M., and Lee, H.B. Demineralized bone particles suppressed the inflammatory reaction of poly(lactide-co-glycolide) scaffold. Tissue Eng Reg Med 3, 295, 2006.
15. Ko, Y.K., Kim, S.H., Ha, H.J., Kim, M.S., Han, C.H., Rhee, J.M., Son, Y., Lee, H.B., and Khang, G. Tissue engineered biodisc using human intervertebral disc cells and PLGA/DBP scaffold. Tissue Eng Reg Med 4, 67, 2007.
16. Jang, J.W., Han, C.W., Kim, M.S., Cho, S.H., Lee, H.B., and Khang, G. Preparation and characterization of demineralized bone particle-loaded PLGA scaffold for tissue engineered bone. Polymer (Korea) 28, 382, 2004.
17. Athanasiou, K.A., Niederauer, G.G., and Agrawal, C.M. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 17, 93, 1996.
18. Sundback, C.A., Shyu, J.Y, Wang, Y, Faquin, W.C., Langer, R.S., Vacanti, J.P., and Hadlock, T.A. Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide materials. Biomaterials 26, 5454, 2005.
19. Dinarello, C.A. Interleukin-1. Rev Infect Dis 6, 51, 1984.
20. Motlagh, D., Yang, J., Lui, K.Y., Webb, A.R., and Ameer, G.A. Hemocompatibility evaluation of poly(glycerol-sebacate) in vitro for vascular tissue engineering. Biomaterials 27, 4315, 2006.
21. Tracey, K.J. and Cerami, A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45, 491, 1994.
22. Le, J. and Vilcek, J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 56, 234, 1987.
23. Gerad, C. Inflammatory chemokines: tuned in, turned on, dropped out. Nat Immunol 6, 366, 2005.
24. Blum, B., Moseley, J., Miller, L., Richelsoph, K., and Haggard, W. Measurement of bone morphogenetic proteins and other growth factors in demineralized bone matrix. Orthopedics 27, 161, 2004.
25. Suganuma, J. and Alexander, H. Biological responses of intramedullary bone to poly-L-lactic acid. J Appl Biomater 4, 13, 1993.